Hypoxia-inducible gene expression system using the erythropoietin enhancer and 3′-untranslated region for the VEGF gene therapy
Authors:
- 28 September 2006
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 115 (1) , 113-119
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Angiogenesis of the heartMicroscopy Research and Technique, 2003
- Myocardial gene therapyNature, 2002
- Angiogenesis, protein and gene deliveryBritish Medical Bulletin, 2001
- VEGF Gene Delivery to MyocardiumCirculation, 2000
- Enhancement of gene expression under hypoxic conditions using fragments of the human vascular endothelial growth factor and the erythropoietin genesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1998
- VEGF Gene Delivery to MuscleMolecular Cell, 1998
- Gene therapy for therapeutic myocardial angiogenesis: A promising synthesis of two emerging technologiesNature Medicine, 1998
- Arterial Gene Transfer for Therapeutic Angiogenesis in Patients with Peripheral Artery Disease. St. Elizabeth's Medical Center, Tufts University School of Medicine, Boston, MassachusettsHuman Gene Therapy, 1996
- Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression.Journal of Clinical Investigation, 1996
- Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model.Journal of Clinical Investigation, 1994